Gelteq Limited Ordinary Shares Stock (NASDAQ:GELS)
Previous Close
$0.68
52W Range
$0.63 - $3.51
50D Avg
$0.74
200D Avg
$1.11
Market Cap
$6.42M
Avg Vol (3M)
$22.37K
Beta
0.04
Div Yield
-
GELS Company Profile
Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. It offers white label gel-based delivery solutions for prescription drugs, over-the-counter products, nutraceuticals and sports, pet care, and other products. The company was incorporated in 2017 and is headquartered in Caulfield, Australia.